Home Menu

Site Navigation



Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome.


advertisement
NeuroTalk Support Groups > > > >

Fipamezole

Reply
 
Thread Tools Display Modes
Old 12-30-2009, 06:59 PM #1
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
  
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
15 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
15 yr Member
Default Fipamezole
Given that we were just discussing the need for research to develop noradrenergic drug therapies that work on the noradrenaline receptors...I am happy to share the news that Santhera in Europe has entered into agreement with Biovail to exclusively produce and market Fipamezole (JP-1730) as treatment for PD - it is in clinical trial and targets controlling dyskinesia and prolongs benefit of levodopa. We need this!!! Stay tuned....Phase III trials in US slated for 2011.


http://www.medicalnewstoday.com/articles/161643.php
Conductor71 is offline   Reply With QuoteReply With Quote

advertisement
Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


All times are GMT -5. The time now is 07:09 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home